On November 8th, 2012, Linda Brzustowicz and James Millonig received the Edison Patent Award from the R & D Council of New Jersey in the medical diagnostic category for their patent "Compositions and Methods of Diagnosing Autism" (U.S. Patent 7,629,123).  This patent's research has, in part, led to the launch of the ARISK Autism Risk Assessment Test by establishing an association between ENGRAILED HOMEOBOX 2 transcription factor (EN2) and susceptibility for Autism and related disorders.